Japan Updates Orphan Drug Designation System to Accelerate Treatments for Rare Diseases
Japan has recently implemented significant updates to its Orphan Drug Designation (ODD) system, aiming to foster the development of treatments for rare diseases. These changes, introduced in 2024, are designed to streamline the designation process, provide robust support to pharmaceutical companies, and expedite patient access to essential medications.